Kiniksa Pharmaceuticals Ltd (KNSA)
16.89
-0.06
(-0.35%)
USD |
NASDAQ |
Apr 18, 16:00
16.89
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals Shareholders Equity (Quarterly): 438.84M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 438.84M |
| September 30, 2023 | 405.13M |
| June 30, 2023 | 411.66M |
| March 31, 2023 | 390.10M |
| December 31, 2022 | 396.15M |
| September 30, 2022 | 384.01M |
| June 30, 2022 | 153.49M |
| March 31, 2022 | 166.24M |
| December 31, 2021 | 185.04M |
| September 30, 2021 | 214.05M |
| June 30, 2021 | 235.78M |
| March 31, 2021 | 270.70M |
| December 31, 2020 | 311.94M |
| Date | Value |
|---|---|
| September 30, 2020 | 358.51M |
| June 30, 2020 | 250.42M |
| March 31, 2020 | 205.83M |
| December 31, 2019 | 225.42M |
| September 30, 2019 | 251.91M |
| June 30, 2019 | 275.20M |
| March 31, 2019 | 306.52M |
| December 31, 2018 | 279.27M |
| September 30, 2018 | 318.91M |
| June 30, 2018 | 341.80M |
| March 31, 2018 | 205.48M |
| December 31, 2017 | -89.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
153.49M
Minimum
Jun 2022
438.84M
Maximum
Dec 2023
291.07M
Average
270.70M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 160.17M |
| Geron Corp | 247.95M |
| United Therapeutics Corp | 5.985B |
| Vanda Pharmaceuticals Inc | 544.91M |
| TG Therapeutics Inc | 160.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 526.32M |
| Total Liabilities (Quarterly) | 87.48M |
| Current Ratio | 4.340 |